Savant Capital LLC Sells 917 Shares of DENTSPLY SIRONA Inc. (NASDAQ:XRAY)

Savant Capital LLC reduced its stake in shares of DENTSPLY SIRONA Inc. (NASDAQ:XRAYFree Report) by 2.7% during the 2nd quarter, Holdings Channel.com reports. The firm owned 33,530 shares of the medical instruments supplier’s stock after selling 917 shares during the quarter. Savant Capital LLC’s holdings in DENTSPLY SIRONA were worth $835,000 at the end of the most recent reporting period.

A number of other hedge funds and other institutional investors have also modified their holdings of XRAY. Truepoint Inc. bought a new position in DENTSPLY SIRONA in the 2nd quarter valued at $2,740,000. Victory Capital Management Inc. increased its position in DENTSPLY SIRONA by 24.8% in the second quarter. Victory Capital Management Inc. now owns 43,061 shares of the medical instruments supplier’s stock worth $1,073,000 after purchasing an additional 8,552 shares during the period. National Bank of Canada FI raised its holdings in DENTSPLY SIRONA by 684.6% during the 2nd quarter. National Bank of Canada FI now owns 876,400 shares of the medical instruments supplier’s stock worth $21,586,000 after purchasing an additional 764,700 shares during the last quarter. Cooke & Bieler LP lifted its position in DENTSPLY SIRONA by 16.2% during the 2nd quarter. Cooke & Bieler LP now owns 7,506,845 shares of the medical instruments supplier’s stock valued at $186,996,000 after purchasing an additional 1,046,105 shares during the period. Finally, Oregon Public Employees Retirement Fund boosted its stake in shares of DENTSPLY SIRONA by 138.7% in the 2nd quarter. Oregon Public Employees Retirement Fund now owns 43,144 shares of the medical instruments supplier’s stock valued at $1,075,000 after purchasing an additional 25,066 shares during the last quarter. Institutional investors and hedge funds own 95.70% of the company’s stock.

Analysts Set New Price Targets

XRAY has been the subject of a number of recent research reports. Needham & Company LLC reissued a “buy” rating and set a $34.00 price target on shares of DENTSPLY SIRONA in a research note on Tuesday, August 20th. Evercore ISI dropped their target price on shares of DENTSPLY SIRONA from $28.00 to $27.00 and set an “outperform” rating for the company in a research report on Tuesday, July 9th. Stifel Nicolaus decreased their price objective on DENTSPLY SIRONA from $30.00 to $28.00 and set a “hold” rating for the company in a research note on Thursday, July 18th. Barrington Research reissued an “outperform” rating and issued a $38.00 target price on shares of DENTSPLY SIRONA in a research note on Monday, July 8th. Finally, Robert W. Baird decreased their target price on DENTSPLY SIRONA from $33.00 to $31.00 and set a “neutral” rating for the company in a research report on Monday, July 22nd. Five investment analysts have rated the stock with a hold rating and seven have issued a buy rating to the company. Based on data from MarketBeat, the stock currently has an average rating of “Moderate Buy” and a consensus price target of $33.44.

Check Out Our Latest Report on XRAY

DENTSPLY SIRONA Price Performance

Shares of XRAY opened at $24.73 on Thursday. The company has a debt-to-equity ratio of 0.57, a quick ratio of 0.87 and a current ratio of 1.33. The firm has a market capitalization of $5.13 billion, a PE ratio of -56.20, a P/E/G ratio of 1.23 and a beta of 1.00. The stock has a 50 day simple moving average of $25.35 and a 200 day simple moving average of $28.23. DENTSPLY SIRONA Inc. has a 52-week low of $23.58 and a 52-week high of $37.60.

DENTSPLY SIRONA (NASDAQ:XRAYGet Free Report) last issued its quarterly earnings data on Wednesday, July 31st. The medical instruments supplier reported $0.49 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.50 by ($0.01). The company had revenue of $984.00 million for the quarter, compared to the consensus estimate of $993.61 million. DENTSPLY SIRONA had a positive return on equity of 11.86% and a negative net margin of 4.75%. The firm’s revenue was down 4.3% on a year-over-year basis. During the same period in the prior year, the company earned $0.51 EPS. Sell-side analysts predict that DENTSPLY SIRONA Inc. will post 1.99 EPS for the current fiscal year.

DENTSPLY SIRONA Dividend Announcement

The company also recently disclosed a quarterly dividend, which will be paid on Friday, October 11th. Investors of record on Friday, September 27th will be issued a dividend of $0.16 per share. The ex-dividend date is Friday, September 27th. This represents a $0.64 dividend on an annualized basis and a dividend yield of 2.59%. DENTSPLY SIRONA’s payout ratio is presently -145.45%.

DENTSPLY SIRONA Profile

(Free Report)

DENTSPLY SIRONA Inc manufactures and sells various dental products and technologies worldwide. It operates in four segments: Connected Technology Solutions, Essential Dental Solutions, Orthodontic and Implant Solutions, and Wellspect Healthcare. The company offers dental equipment comprising imaging equipment, motorized dental handpieces, treatment centers, other instruments, amalgamators, mixing machines, and porcelain furnaces; and dental CAD/CAM technologies to support dental restorations, such as intraoral scanners, 3-D printers, mills, other software and services, and a full-chairside economical restoration of esthetic ceramic dentistry, as well as DS Core, its cloud-based platform.

Featured Stories

Want to see what other hedge funds are holding XRAY? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for DENTSPLY SIRONA Inc. (NASDAQ:XRAYFree Report).

Institutional Ownership by Quarter for DENTSPLY SIRONA (NASDAQ:XRAY)

Receive News & Ratings for DENTSPLY SIRONA Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for DENTSPLY SIRONA and related companies with MarketBeat.com's FREE daily email newsletter.